论文部分内容阅读
目的观察托特罗定片治疗女性膀胱过度活动症的有效性和安全性。方法将204例女性膀胱过度症患者随机分为两组,实验组107例,给予盐酸托特罗定片2mg;对照组97例,给予盐酸托特罗定片2mg,联合应用盐酸丙哌唯林片(10mg/片)20mg,疗程均为2个月。结果治疗2个月后,实验组和对照组的有效率分别为88.8%和85.6%,差异不具统计学意义(P>0.05);实验组治疗前后平均24h排尿次数、平均24h尿失禁次数、平均每次排尿量均有显著改善(P<0.05);两组均未发现严重不良反应。结论单独应用盐酸托特罗定片治疗女性膀胱过度活动症安全有效,与盐酸丙哌唯林片治疗效果不具相加作用。
Objective To observe the efficacy and safety of tolterodine in the treatment of female overactive bladder. Methods Totally 204 female patients with overactive bladder were randomly divided into two groups. The experimental group consisted of 107 patients receiving tolterodine hydrochloride 2mg and the control group 97 patients receiving tolterodine hydrochloride 2mg combined with propofive hydrochloride Tablets (10mg / tablet) 20mg, treatment were 2 months. Results After two months of treatment, the effective rates of the experimental group and the control group were 88.8% and 85.6%, respectively, with no significant difference (P> 0.05). The average number of urinary 24-hour urination and the average number of 24-hour incontinence before and after treatment in the experimental group were Each urination volume was significantly improved (P <0.05); no serious adverse reactions were found in both groups. Conclusion The application of tolterodine alone in the treatment of overactive bladder in women is safe and effective, with no additive effect with the treatment effect of promethazine hydrochloride tablets.